|Bid||0.0000 x 40700|
|Ask||0.0000 x 1200|
|Day's range||0.1900 - 0.2000|
|52-week range||0.1900 - 2.0900|
|Beta (5Y monthly)||1.21|
|PE ratio (TTM)||0.55|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||13 Jan 2023|
|1y target est||N/A|
Catalyst Biosciences ( NASDAQ:CBIO ) Third Quarter 2022 Results Key Financial Results Net loss: US$4.88m (loss narrowed...
Over the last year, a good number of insiders have significantly increased their holdings in Catalyst Biosciences, Inc...
Catalyst Biosciences, Inc. ( NASDAQ:CBIO ) shareholders will doubtless be very grateful to see the share price up 45...